News Feature


Nature Biotechnology 26, 1327 - 1329 (2008)
doi:10.1038/nbt1208-1327

Hypertension's shot in the arm

Jill U. Adams1

  1. Albany, New York


Two small companies developing therapeutic vaccines against hypertension are blazing a trail for immune treatments that address diseases of lifestyle with massive markets. But doubts linger over the safety of eliciting an immune response to normal body constituents. Jill U. Adams investigates.

Top


MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.